TherapeuticsMD TXMD Q4 2024 Annual earnings
Reported March 27, 2025
Revenue estimate$2.3M
EPS estimate$0.04
Next report
Aug 17, 2026 (in a month)Revenue estimate$22.1M
EPS estimate-$5.50
Versus estimates
Revenue
Q1 2026$724.0KMiss by $19.0MQ4 2025$893.0KMiss by $18.9MQ3 2025$784.0KQ2 2025$952.0KQ1 2025$393.0K
Q4 2024$667.0KMiss by $1.6M
Diluted EPS
Q1 2026$0.01Beat by $6.14Q4 2025-$0.05Beat by $6.07Q3 2025$0.01Q2 2025$0.05Q1 2025-$0.06
Q4 2024$0.02Miss by $0.02
Ask the moment TherapeuticsMD reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did TherapeuticsMD report Q4 2024 earnings?
- TherapeuticsMD (TXMD) reported Q4 2024 earnings on March 27, 2025.
- What were TherapeuticsMD's Q4 2024 revenue and EPS?
- TherapeuticsMD reported revenue of $667.0K and diluted EPS of $0.02 for Q4 2024.
- Did TherapeuticsMD beat estimates in Q4 2024?
- Revenue missed the consensus estimate of $2.3M by $1.6M. EPS missed the consensus estimate of $0.04 by $0.02.
- Where can I find TherapeuticsMD's Q4 2024 SEC filings?
- You can read the 10-K periodic report (0001013762-25-003442) directly on SEC EDGAR. The filing index links above go to sec.gov.